Latest News | Abbott Launches Next Gen Heart Rhythm Management Devices in India

New Delhi, Oct 14 (PTI) Healthcare major Abbott on Wednesday said it has launched next-generation heart rhythm management devices in India.

The company has introduced its new Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronisation Therapy Defibrillator (CRT-D) devices for  people with abnormal heart rhythms and heart failure, the drug major said in a statement.

Also Read | Aadhaar Myth Buster: Can Someone Hack Your Bank Account if They Get to Know Your 12-Digit Unique Aadhaar Number? Here's the Fact.

The devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications, it added.

Additional benefits include a patient preferred design, improved battery longevity and MRI compatibility, Abbott said.

Also Read | Winter Could Be Colder This Season Due to Prevailing La Nina Conditions, Says IMD DG.

"The positive impact of remote monitoring has been proven repeatedly and leads to better patient outcomes," Abbott's Cardiac Rhythm Management business divisional vice president and chief medical officer Avi Fischer said.

The devices provide people the ability to connect to their doctor anytime, even while away from home, and reinforces its commitment to incorporate advanced technologies that will help improve engagement between patients, caregivers and doctors, he added.

Abbott employs over one lakh people in more than 160 countries. The company employs around 12,000 people in India.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)